Ultreon 3.0 uses AI and OCT to provide real-time, high-resolution imaging during minimally invasive heart procedures.
Through working with OpenAI, Massive Bio converts complex clinical trial criteria into machine-readable formats.
A PRV is issued by the FDA to sponsors whose products address certain rare paediatric diseases.
The funds will support further development of Nervonik’s sensing technology and commercialisation of its PNS platform.
